#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinoblastoma Thermal burn Brain abscess Myelin oligodendrocyte glycoprotein antibody-associated disease HER2 mutant non-small cell lung cancer Chronic hepatitis B Allogenic stem cell transplantation Bronchopulmonary dysplasia Acquired C1 inhibitor deficiency Angiosarcoma metastatic Aplastic anaemia Osteopetrosis Von Willebrand's disease Acute graft versus host disease in intestine Urethral valves More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III Alagille syndrome – Trials in Disease Von Willebrand’s disease Behcet’s syndrome – Treatment Adrenogenital syndrome – Treatment Tuberous sclerosis complex Myxofibrosarcoma – Diagnostics Primary immunodeficiency syndrome – Basic Information Shprintzen-Goldberg syndrome Metachromatic leukodystrophy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zetomipzomib Cangrelor Tetrasodium Crd-4730 Dsimc Metolazone Chlorphenamine Maleate Alclometasone Dipropionate Obexelimab Ovolecithin Neostigmine Methylsulfate Caplacizumab Dasiglucagon Lactulose Mebendazole Csm-Gw Beclometasone Dipropionate Interferon Beta-1B Cortisone Acetate Pariglasgene Brecaparvovec Nimodipine More therapies…

    Learn about Your Condition

    Anal fissure Haemodynamic instability Exfoliation glaucoma Cataract Radius fracture Double hit lymphoma Pituitary tumour benign Supraventricular tachycardia Tumour thrombosis Acute kidney injury Ovarian cancer stage III Device related infection Obstructive pancreatitis Transient ischaemic attack Corneal graft rejection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Eivy Franke Beckmann

Eivy Franke Beckmann

Ammertalweg 7, Ilversgehofen, Erfurt, 99086, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Meningococcal infection
    Investigated Drugs:
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    • Neisseria Meningitidis Group A Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    • Neisseria Meningitidis Group W-135 Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    Czechia Denmark Finland Germany Poland Romania
  • Study on the Effect of a New Moisturiser with Paraffin and Liquid Paraffin on Preventing Eczema Relapse in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Eczema
    • Dermatitis atopic
    Investigated Drugs:
    • Liquid Paraffin
    • Methylprednisolone Aceponate
    • Paraffin White Soft
    Germany Sweden

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!